Near-infrared photoimmunotherapy (NIR-PIT) is a recently developed targeted molecular cancer therapy that combines a target-specific photosensitizer based on the infrared phthalocyanine dye IR700 with a monoclonal antibody against epidermal growth factor receptor (EGFR) (9). This evidence concerns the gene EGFR and cancer.